Overhaul 'made-to-order' drugs, which cost NHS millions, urges DTB
Wednesday, October 6, 2010 - 03:01
in Health & Medicine
The provision of made-to-order drugs ("specials") in primary care is expensive, often unnecessary, and associated with legal pitfalls, says the Drug and Therapeutics Bulletin (DTB).